Titlebook: Angiogenesis and Direct Myocardial Revascularization; Roger J. Laham,Donald S. Baim Book 2005 Humana Press 2005 Chemokine.angiogenesis.car

adulterant

平淡而無味

Schirmd?mpfung an Schichten für Leitungenads to symptoms of heart failure in a significant number of patients. For conventional coronary revascularization to be beneficial, viable myocardium must be present. The prognosis for these patients is poor, with a 1-yr mortality rate of 20% and a 5-yr mortality rate of close to 50% (.).

艦旗

Ccu106

Sleep-Paralysis

Myocardial Angiogenesis,es for CABG or PCI or receive incomplete revascularization with current revascularization strategies (.–.). As a result, many of these patients have residual symptoms and limited quality of life despite maximal medical therapy (frequently described as “refractory angina pectoris”) (.,.). Therefore,

誰在削木頭

Bone Marrow Cell Transplantation for Myocardial Regeneration and Therapeutic Angiogenesis,n (angiogenesis) and growing new heart muscle fibers (myocardial regeneration) are attractive alternatives. Accumulating evidence suggests that bone marrow cells have the potential of contributing to tissue revascularization and cardiac regeneration after myocardial injury. This chapter summarizes t

FRAX-tool

Transplantation of Embryonic Stem Cells for Myocardial Regeneration and Angiogenesis,en referred to as regenerative or reparative medicine. Stem cell-based cellular cardiomyoplasty (CCM) for cardiomyocyte replacement/regeneration has been evaluated in animal settings (.–.) and clinical trials (.–.). Transplantation of exogenous stem cells could regenerate damaged myocardium and impr

Emg827

朦朧

No-Option Patients, the leading cause of morbidity and mortality in the Western Hemisphere. Cardiovascular disease accounted for 38.5% of all deaths or 1 of every 2.6 deaths in the United States in 2001. Cardiovascular disease mortality was about 60% of “total mortality,” i.e., of over 2,400,000 deaths from all causes

Hot-Flash

Transcriptional Regulation of Angiogenesis,elopmental processes, such as hematopoiesis and myogenesis, in which several cell- or tissue-specific transcription factors have been identified. Vascular development requires the differentiation of endothelial cells from pluripotent stem cells. Progress in identifying the molecular mechanisms under